跳至主要内容
临床试验/CTRI/2024/12/078264
CTRI/2024/12/078264尚未招募2 期

Efficacy and safety profile of topical ivermectin and topical metronidazole in steroid induced rosacea in tertiary care teaching hospital.

Dr CHIRAG SAINI1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2024年12月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
1.To compare the efficacy of 2 % metronidazole gel and 1% ivermectin cream in steroid induced rosacea.

研究概览

简要总结

The study will be conducted to see the efficacy of topical ivermectin & topical metronidazole in steroid induced rosacea. Topical steroids being prescribed by many professionals for various skin conditions, easy availability at nearby pharmacies, at very cheap prices, and with no regulation on their sale as an OTC drug, the need to study about the remedies for the side effects caused by topical steroid abuse is an absolute necessity.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients of either sex, 18-65 years age, with steroid induced rosacea.
  • Patient is off topical steroids for at-least 2 weeks.

排除标准

  • Pregnant and Lactating Women.
  • Drug allergy.
  • Children less than 18 years
  • Patients with Autoimmune Connective Tissue disease.
  • Associated Acne patients.

结局指标

主要结局

1.To compare the efficacy of 2 % metronidazole gel and 1% ivermectin cream in steroid induced rosacea.

时间窗: Patients will be followed up on 3th, 6th, 9th and 12th week

次要结局

  • Study the safety profile of 2% metronidazole gel and 1% ivermectin cream.(Patients will be followed up on 3th, 6th, 9th and 12th week)

研究者

发起方
Dr CHIRAG SAINI
申办方类型
Other [Self sponsored ]
责任方
Principal Investigator
主要研究者

Dr CHIRAG SAINI

Government Medical College Haldwani

研究点 (1)

Loading locations...

相似试验